Your topics. New publications.

A compact browser notification when there’s something new. At most once a day — no account needed.

What interests you?

Optional and switchable off here at any time. We save your selected topics and device subscription; no email address is required. Privacy

Search the harborEN/DEAccount
Nutrition foundations
Research brief

Rat study: maternal diabetes and high-fat diet across two generations

In rats, maternal diabetes and a high-fat diet were linked to changes in pancreatic islet cells in female offspring and their newborns; this is animal research, not evidence about human lifespan. [1]

Automatic summary · not editorially reviewed

The key findings

  1. Female Sprague-Dawley rats were divided into four groups of ten by maternal diabetes status and standard or high-fat diet. [1]

  2. Offspring of diabetic dams on the high-fat diet had 14.5% fewer glucagon-positive cells than the other groups. [1]

  3. The authors suggest maternal diabetes, regardless of high-fat diet, may predispose female offspring to pancreatic dysfunction and metabolic disease risk. [1]

The source at a glance

Study type / format
Animal study (rat), abstract only
Population / context
Female Sprague-Dawley rats (F1) and their offspring (F2), grouped by maternal diabetes status and diet.
Summary based on
Study abstract
Original publication
October 8, 2026

Rat dams, diet and diabetes groups

Female Sprague-Dawley rats (F1) were split into four groups of ten: offspring of non-diabetic dams on a standard diet, offspring of non-diabetic dams on a high-fat diet, offspring of diabetic dams on a standard diet, and offspring of diabetic dams on a high-fat diet. At postnatal day 90, in adulthood, these F1 females were mated and euthanized on gestational day 21 so their pancreases could be collected for immunochemistry and morphological analysis. Their offspring (F2) were also obtained for pancreatic evaluation.

Supporting source [1]

Islet cell changes in F1 and F2 offspring

Offspring of diabetic dams on the high-fat diet showed 14.5% fewer glucagon-positive cells than the other groups. Compared with offspring of non-diabetic dams on the standard diet, the high-fat-diet group, the diabetic-dam standard-diet group and the diabetic-dam high-fat-diet group had more somatostatin-positive cells (43.8%), more cleaved caspase-3-positive cells (30.2%) and more 4-HNE-positive cells (over 100%), plus fewer Ki-67-positive cells. Newborns of non-diabetic dams on the high-fat diet had higher proportions of insulin-, glucagon- and somatostatin-positive cells than newborns of the other dams.

Supporting source [1]

What the rat findings can and cannot show

The authors conclude that maternal diabetes, regardless of high-fat diet exposure, may predispose female offspring to future pancreatic dysfunction and a higher risk of metabolic disease, and they highlight a sex-specific vulnerability of females to transgenerational programming. These are associations in rats, not proof of cause in humans, and the abstract does not report human data or lifespan outcomes. Only the abstract was reviewed; the full text was not reviewed.

Supporting source [1]

How to interpret this

Abstract only; the full text was not reviewed. This is a rat study with no human data or lifespan outcomes reported, and the findings are associations, not proof of cause.

Based on the study abstract; the full paper, tables and supplementary data were not reviewed.

Source & supporting passages

[1]
Maternal Diabetes and a High-Fat Diet Program Transgenerational Dysfunction of the Endocrine Pancreas in Offspring.

Gallego FQ, Barco VS, Sinzato YK, Paula VG, de Souza MR, da Cruz LL, Corrente JE, Volpato GT, Damasceno DC. · europepmc.org · October 8, 2026

Read the quoted passagesIn the language of the original source
  1. Finding 1 ↑

    allocated into four groups (n=10/group)
  2. Finding 2 ↑

    14.5% reduction in glucagon‑positive cells
  3. Finding 3 ↑

    predisposes female offspring to future pancreatic dysfunction

AI-assisted summary with linked source passages. No independent editorial or clinical review.

Our editorial method

Discussion

Community discussions

0 topics

Member contributions. Share sources, disclose commercial interests, and avoid personal medical or dosing advice.

Loading…